Literature DB >> 20405279

Is etomidate really that bad in septic patients?

Fabio Moreira Andrade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20405279     DOI： 10.1007/s00134-010-1878-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  ICU physicians should abandon the use of etomidate!

Authors:  Djillali Annane
Journal:  Intensive Care Med       Date:  2005-01-27       Impact factor: 17.440

2.  Etomidate: not worth the risk in septic patients.

Authors:  Alfred Sacchetti
Journal:  Ann Emerg Med       Date:  2008-07       Impact factor: 5.721

3.  Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock.

Authors:  Ron M Walls; Michael F Murphy
Journal:  Ann Emerg Med       Date:  2008-07       Impact factor: 5.721

Review 4.  Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal.

Authors:  William L Jackson
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

Review 5.  Etomidate for rapid sequence intubation in the emergency department: is adrenal suppression a concern?

Authors:  Peter J Zed; Vincent H Mabasa; Richard S Slavik; Riyad B Abu-Laban
Journal:  CJEM       Date:  2006-09       Impact factor: 2.410

6.  Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study.

Authors:  Amy N Hildreth; Vicente A Mejia; Robert A Maxwell; Philip W Smith; Benjamin W Dart; Donald E Barker
Journal:  J Trauma       Date:  2008-09

7.  Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.

Authors:  Patricia Jabre; Xavier Combes; Frederic Lapostolle; Mohamed Dhaouadi; Agnes Ricard-Hibon; Benoit Vivien; Lionel Bertrand; Alexandra Beltramini; Pascale Gamand; Stephane Albizzati; Deborah Perdrizet; Gaelle Lebail; Charlotte Chollet-Xemard; Virginie Maxime; Christian Brun-Buisson; Jean-Yves Lefrant; Pierre-Edouard Bollaert; Bruno Megarbane; Jean-Damien Ricard; Nadia Anguel; Eric Vicaut; Frederic Adnet
Journal:  Lancet       Date:  2009-07-01       Impact factor: 79.321

8.  Duration of adrenal inhibition following a single dose of etomidate in critically ill patients.

Authors:  Marc Vinclair; Christophe Broux; Patrice Faure; Julien Brun; Céline Genty; Claude Jacquot; Olivier Chabre; Jean-François Payen
Journal:  Intensive Care Med       Date:  2007-12-18       Impact factor: 17.440

9.  The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.

Authors:  Brian H Cuthbertson; Charles L Sprung; Djillali Annane; Sylvie Chevret; Mark Garfield; Serge Goodman; Pierre-Francois Laterre; Jean Louis Vincent; Klaus Freivogel; Konrad Reinhart; Mervyn Singer; Didier Payen; Yoram G Weiss
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

10.  Adrenal response in patients with septic shock of abdominal origin: relationship to survival.

Authors:  Florence C Riché; Carole M Boutron; Patrice Valleur; Christine Berton; Marie-Josèphe Laisné; Jean-Marie Launay; Philippe Chappuis; Jacqueline Peynet; Eric Vicaut; Didier Payen; Bernard P Cholley
Journal:  Intensive Care Med       Date:  2007-07-06       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.